These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
173 related articles for article (PubMed ID: 16078264)
41. Preoperative hydronephrosis as an indicator of survival after radical cystectomy. Chapman DM; Pohar KS; Gong MC; Bahnson RR Urol Oncol; 2009; 27(5):491-5. PubMed ID: 18657452 [TBL] [Abstract][Full Text] [Related]
42. The prognostic impact of pelvic lymph node metastasis and lymphovascular invasion on bladder cancer. Herrmann E; Stöter E; van Ophoven A; Bierer S; Bolenz C; Hertle L; Wülfing C Int J Urol; 2008 Jul; 15(7):607-11. PubMed ID: 18462352 [TBL] [Abstract][Full Text] [Related]
43. Standardization of pelvic lymphadenectomy performed at radical cystectomy: can we establish a minimum number of lymph nodes that should be removed? Koppie TM; Vickers AJ; Vora K; Dalbagni G; Bochner BH Cancer; 2006 Nov; 107(10):2368-74. PubMed ID: 17041887 [TBL] [Abstract][Full Text] [Related]
44. Marital status and survival following bladder cancer. Datta GD; Neville BA; Kawachi I; Datta NS; Earle CC J Epidemiol Community Health; 2009 Oct; 63(10):807-13. PubMed ID: 19468015 [TBL] [Abstract][Full Text] [Related]
45. A retrospective review with long term follow up of 11,400 cases of pure mucinous breast carcinoma. Di Saverio S; Gutierrez J; Avisar E Breast Cancer Res Treat; 2008 Oct; 111(3):541-7. PubMed ID: 18026874 [TBL] [Abstract][Full Text] [Related]
46. Clinical outcomes and recurrence predictors of lymph node positive urothelial cancer after cystectomy. Bruins HM; Huang GJ; Cai J; Skinner DG; Stein JP; Penson DF J Urol; 2009 Nov; 182(5):2182-7. PubMed ID: 19758623 [TBL] [Abstract][Full Text] [Related]
47. Radical prostatectomy for clinical T4 prostate cancer. Johnstone PA; Ward KC; Goodman M; Assikis V; Petros JA Cancer; 2006 Jun; 106(12):2603-9. PubMed ID: 16700037 [TBL] [Abstract][Full Text] [Related]
48. Cystectomy for muscle-invasive bladder cancer: patterns and outcomes of care in the Medicare population. Schrag D; Mitra N; Xu F; Rabbani F; Bach PB; Herr H; Begg CB Urology; 2005 Jun; 65(6):1118-25. PubMed ID: 15922428 [TBL] [Abstract][Full Text] [Related]
49. Clinical outcome of tumor recurrence for Ta, T1 non-muscle invasive bladder cancer from the data on registered bladder cancer patients in Japan: 1999-2001 report from the Japanese Urological Association. Kikuchi E; Fujimoto H; Mizutani Y; Okajima E; Koga H; Hinotsu S; Shinohara N; Oya M; Miki T; Int J Urol; 2009 Mar; 16(3):279-86. PubMed ID: 19207609 [TBL] [Abstract][Full Text] [Related]
50. Expression of cyclooxygenase-2 in normal urothelium, and superficial and advanced transitional cell carcinoma of bladder. Margulis V; Shariat SF; Ashfaq R; Thompson M; Sagalowsky AI; Hsieh JT; Lotan Y J Urol; 2007 Mar; 177(3):1163-8. PubMed ID: 17296438 [TBL] [Abstract][Full Text] [Related]
51. The significance of lymphovascular invasion in transurethral resection of bladder tumour and cystectomy specimens on the survival of patients with urothelial bladder cancer. Streeper NM; Simons CM; Konety BR; Muirhead DM; Williams RD; O'Donnell MA; Joudi FN BJU Int; 2009 Feb; 103(4):475-9. PubMed ID: 18990174 [TBL] [Abstract][Full Text] [Related]
52. Lymph node evaluation is associated with improved survival after surgery for early stage gallbladder cancer. Jensen EH; Abraham A; Jarosek S; Habermann EB; Al-Refaie WB; Vickers SA; Virnig BA; Tuttle TM Surgery; 2009 Oct; 146(4):706-11; discussion 711-3. PubMed ID: 19789030 [TBL] [Abstract][Full Text] [Related]
53. Nomogram for predicting disease recurrence after radical cystectomy for transitional cell carcinoma of the bladder. Karakiewicz PI; Shariat SF; Palapattu GS; Gilad AE; Lotan Y; Rogers CG; Vazina A; Gupta A; Bastian PJ; Perrotte P; Sagalowsky AI; Schoenberg M; Lerner SP J Urol; 2006 Oct; 176(4 Pt 1):1354-61; discussion 1361-2. PubMed ID: 16952631 [TBL] [Abstract][Full Text] [Related]
54. Concomitant carcinoma in situ is a feature of aggressive disease in patients with organ-confined TCC at radical cystectomy. Shariat SF; Palapattu GS; Karakiewicz PI; Rogers CG; Vazina A; Bastian PJ; Schoenberg MP; Lerner SP; Sagalowsky AI; Lotan Y Eur Urol; 2007 Jan; 51(1):152-60. PubMed ID: 17011114 [TBL] [Abstract][Full Text] [Related]
55. Serum tumor markers may predict overall and disease specific survival in patients with clinically organ confined invasive bladder cancer. Margel D; Tal R; Baniel J J Urol; 2007 Dec; 178(6):2297-300; discussion 2300-1. PubMed ID: 17936837 [TBL] [Abstract][Full Text] [Related]
56. [New markers for pharmacological targeting in bladder cancer with lymph node metastasis]. Herrmann E; Eltze E; Köpke T; Bolenz C; Bierer S; Neumann J; Hertle L; Wülfing C Aktuelle Urol; 2007 Sep; 38(5):392-7. PubMed ID: 17907066 [TBL] [Abstract][Full Text] [Related]
57. Long-term oncological outcomes in women undergoing radical cystectomy and orthotopic diversion for bladder cancer. Stein JP; Penson DF; Lee C; Cai J; Miranda G; Skinner DG J Urol; 2009 May; 181(5):2052-8; discussion 2058-9. PubMed ID: 19286213 [TBL] [Abstract][Full Text] [Related]